Biotechnology Annual ReviewBy
- M. Raafat El-Gewely
Biotechnology is a diverse, complex and rapidly evolving field. Students and experienced researchers alike face the challenges of staying on top of developments in their field of specialty and maintaining a broader overview of the field as a whole. Volumes containing competent reviews on a diverse range of topics in the field fulfill the dual role of broadening and updating biotechnologistsâ knowledge. The current volume is an excellent example of such a book. The topics covered range from classical issues in biotechnology - such as, vehicles for the production of biotechnology products and methods for their detection, separation and analysis - to topics that are focused on the role of biotechnology in the health sciences. The information presented in this book will therefore will be of great value to both experienced biotechnologists and biotechnologists in training.
Researchers in life science and biotechnology fields.
Biotechnology Annual Review
Hardbound, 452 Pages
Published: July 2005
- Foreword (Ruedi Aebersold, Institute of Biotechnology, Swiss Federal Institute of Technology, ZÃ¼rich, Switzerland)Towards quantitative biology: Integration of biological information to elucidate disease pathways and to guide drug discovery;The Duckweeds â A Valuable Plant for Biomanufacturing;The Application of BacMam Technology in Nuclear Receptor Drug Discovery;Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction; Display libraries on bacteriophage lambda capsid;Vibrational spectroscopy formolecular characterization and diagnosis of benign, premalignant and malignant skin tumors;Cell and tissue autofluorescenc research and diagnostic applications;Sterilisation in biotechnology;CIM Convective Interaction MediaÃ - short layer monolithic chromatographic stationary phases;Detection of metazoan species as a public health issue: simple methods for the validation of food safety and quality;Water echology of Legionella and Protozoans: environmental and public health perspectives;A Prospective, Nonrandomized Phase 1-2 Trial of VACOP-B With Filgrastim Support for HIV-Related Non-Hodgkinâs Lymphoma;Cell Migration/Invasion Assays and their Application in Cancer Drug Discovery